Carestream Health recently secured an agreement with Distribuidora Diagnostica Medica SAC
News | Cardiovascular Business
Carestream Secures Crucial Business Partner Agreement in Peru

June 18, 2024 — Carestream Health recently secured an agreement with Distribuidora Diagnostica Medica SAC (DMD), a ...

Home June 18, 2024
Home
Despite significant advances in prevention and treatment, Black Americans have higher risk of cardiovascular death
News | Heart Failure
JACC Report Card Highlights Inequities in CV Care, Death Rates

June 18, 2024 — As we commemorate Juneteenth 2024, JACC, the flagship journal of the American College of Cardiology, has ...

Home June 18, 2024
Home
At least 6 in 10 adults in an older, more diverse U.S. population could be affected by cardiovascular disease within the next 30 years, according to two new science reports from the American Heart Association (AHA).
News | AHA
Heart Disease and Stroke Could Affect at Least 60% of Adults in U.S. by 2050, According to American Heart Association Advisories

June 18, 2024 — At least 6 in 10 adults in an older, more diverse U.S. population could be affected by cardiovascular ...

Home June 18, 2024
Home
Elixir Medical has announced the company’s novel bioadaptive implant, DynamX Sirolimus-Eluting Coronary Bioadaptor System, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
News | FDA
Elixir Medical Granted FDA Breakthrough Device Designation for DynamX Bioadaptor

June 18, 2024 — Elixir Medical has announced the company’s novel bioadaptive implant, DynamX Sirolimus-Eluting Coronary ...

Home June 18, 2024
Home
Medtronic launched the Steerant Aortic Guidewire, tailored to facilitate catheter placement and exchange during diagnostic or interventional procedures in the aorta
News | Guidewires
Medtronic Launches Steerant Aortic Guidewire for EVAR and TEVAR Procedures

June 17, 2024 — Medtronic launched the Steerant Aortic Guidewire, tailored to facilitate catheter placement and exchange ...

Home June 17, 2024
Home
EluPro becomes the only drug-eluting biologic envelope to receive FDA clearance in the $600 million U.S. implantable electronic device protection market
News | FDA
Elutia Announces FDA Clearance of EluPro: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators

June 17, 2024 — Elutia Inc., a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting ...

Home June 17, 2024
Home
aycan now offers AI solution for cardiology, enabling further expansion into that market and the growing medical AI solution space
News | Artificial Intelligence
aycan becomes a reseller and technology partner of AI4MedImaging

June 17, 2024 — aycan, a recognized leader in medical imaging, announced today a reseller and technology partnership ...

Home June 17, 2024
Home
In a study, machine-learning models identified a range of risks among patients who had experienced this sentinel event.
News | Electronic Medical Records (EMR)
Can a Medical Record Predict Cardiac Arrest Risk?

June 14, 2024 — Until now, known risk factors for cardiac arrest have been limited to cardiovascular conditions such as ...

Home June 14, 2024
Home
The CPIC will be a leading advocate for fair and transparent coverage and reimbursement policies that facilitate access to cardiac PET
News | PET Imaging
Positron Corporation Joins Cardiac PET Industry Coalition (CPIC)

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Home June 14, 2024
Home
Next-generation Avalus Ultra valve is Medtronic’s most advanced surgical aortic tissue valve built on 10 years of clinical experience with the Avalus valve
News | Cardiovascular Surgery
Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest ...

Home June 13, 2024
Home
Xeltis synthetic restorative pulmonary heart valve evolves into a fully functioning, natural heart valve through colonization by the patient’s own tissue.
News | FDA
Xeltis Receives IDE Approval from FDA for Initiation of US Pivotal Trial for aXess, its Restorative Vascular Access Conduit

June 13, 2024 — Xeltis, a leading developer of transformative implants that enable the natural creation of living and ...

Home June 13, 2024
Home
Dr. Frederick St. Goar honored with prestigious Andreas Grüntzig Ethica Award
News | Cardiovascular Business
El Camino Health Cardiologist Earns International Award for Achievements in Advancing Cardiovascular Field

June 13, 2024 — Frederick St. Goar, MD, medical director at the Norma Melchor Heart & Vascular Institute, was ...

Home June 13, 2024
Home
The Arrow FiberOptix and UltraFlex Intra-Aortic Balloon (IAB) Catheter Kits are being recalled for manufacturing issues that may prevent full balloon inflation and cause patient harm
News | Balloon Catheter
FDA Announces Teleflex/Arrow International Recall Arrow FiberOptix and UltraFlex Intra-Aortic Balloon (IAB) Catheter Kits

June 13, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and their subsidiary Arrow ...

Home June 13, 2024
Home
Medical device company Visura Technologies, Inc. has announced the TEECADE mini, an initiative for the next innovation in transesophageal echocardiography (TEE) imaging technology. The company, led by President & CEO Christine Horton, will be participating in the American Society of Echocardiography Scientific Sessions (ASE 2024) to be held June 14-16 in Portland, OR.
News | Transesophageal Echo (TEE)
Visura Technologies to Feature TEECAD mini for Use with Smaller Transesophageal Echocardiography (TEE) Probes During ASE 2024

June 13, 2024 — Visura Technologies, Inc., a privately owned medical device company, has announced the TEECADE mini, an ...

Home June 13, 2024
Home
Sanger Heart and Vascular Institute, Atrium Health, treated the first patient with the new implantable medical device following FDA premarket approval
News | Stents
Philips launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction

June 12, 2024 — Royal Philips, a global leader in health technology, announced the first implant of the Duo Venous Stent ...

Home June 12, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now